These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 29436090)
1. Neuroscience-based Nomenclature: What is it, why is it needed, and what comes next? Uchida H Psychiatry Clin Neurosci; 2018 Feb; 72(2):50-51. PubMed ID: 29436090 [No Abstract] [Full Text] [Related]
2. Neuroscience-based nomenclature (jNbN) to replace traditional terminology of psychotropic medications. Möller HJ; Schmitt A; Falkai P Eur Arch Psychiatry Clin Neurosci; 2016 Aug; 266(5):385-6. PubMed ID: 27216433 [No Abstract] [Full Text] [Related]
3. A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature. Zohar J; Stahl S; Moller HJ; Blier P; Kupfer D; Yamawaki S; Uchida H; Spedding M; Goodwin GM; Nutt D Eur Neuropsychopharmacol; 2015 Dec; 25(12):2318-25. PubMed ID: 26527055 [TBL] [Abstract][Full Text] [Related]
9. Tightrope or Slackline? The Neuroscience of Psychoactive Substances. Coulon P; Gorji A Trends Pharmacol Sci; 2016 Jul; 37(7):511-521. PubMed ID: 27156438 [TBL] [Abstract][Full Text] [Related]
10. Neuroscience-based Nomenclature: improving clinical and scientific terminology in research and clinical psychopharmacology. Brühl AB; Sahakian BJ Psychol Med; 2017 Jun; 47(8):1339-1341. PubMed ID: 28095940 [No Abstract] [Full Text] [Related]
11. What's in a Name? Moving to Neuroscience-Based Nomenclature in Pediatric Psychopharmacology. Sultan RS; Correll CU; Zohar J; Zalsman G; Veenstra-VanderWeele J J Am Acad Child Adolesc Psychiatry; 2018 Oct; 57(10):719-721. PubMed ID: 30274643 [TBL] [Abstract][Full Text] [Related]
12. Herbal medicine for psychiatric disorders: Psychopharmacology and neuroscience-based nomenclature. Tang SW; Tang WH; Leonard BE World J Biol Psychiatry; 2019 Oct; 20(8):586-604. PubMed ID: 28649903 [No Abstract] [Full Text] [Related]
13. Using neuroscience for naming psychotropic drugs. Stahl SM CNS Spectr; 2016 Jun; 21(3):219-20. PubMed ID: 27322688 [No Abstract] [Full Text] [Related]
14. [Neuroscience-Based Nomenclature for Psychotropic Drugs: Four Reasons to Use and Keep it in Portugal]. Gouveia A; Martins F; Trindade P; Jesus G; M Bessa J; Heitor MJ; Câmara Pestana L; Fernandes LA; Morgado P; Oliveira-Maia AJ Acta Med Port; 2024 Mar; 37(3):155-159. PubMed ID: 38430470 [No Abstract] [Full Text] [Related]
15. The Neuroscience-based Nomenclature Child & Adolescent (NbN C&A) for Psychotropic Medications: Innovation in Progress. Cortese S; Singh MK; Novins DK J Am Acad Child Adolesc Psychiatry; 2022 Nov; 61(11):1317-1318. PubMed ID: 35697264 [TBL] [Abstract][Full Text] [Related]
16. 22nd Symposium of the AGNP. Nuremberg, September 26-29, 2001. Abstracts. Pharmacopsychiatry; 2001 Sep; 34(5):161-216. PubMed ID: 11588671 [No Abstract] [Full Text] [Related]
17. Abstracts of the 15th Congress of the European College of Neuropsychopharmacology. Barcelona, Spain, 5-9 October 2002. Eur Neuropsychopharmacol; 2002 Oct; 12 Suppl 3():S77-457. PubMed ID: 12418468 [No Abstract] [Full Text] [Related]
18. Abstracts of the 3rd European College of Neuropsychopharmacology Workshop. Nice, France, March 15-17, 2002. Eur Neuropsychopharmacol; 2002 Mar; 12 Suppl 1():S1-S24. PubMed ID: 11858956 [No Abstract] [Full Text] [Related]
20. Abstracts of the 16th Congress of the European College of Neuropsychopharmacology. Prague, Czech Republic, September 20-24, 2003. Eur Neuropsychopharmacol; 2003 Sep; 13 Suppl 4():S93-488. PubMed ID: 14524345 [No Abstract] [Full Text] [Related] [Next] [New Search]